Mobia Medical, Inc. - Common Stock (MOBI)

Revenue doubled as Vivistim unit sales and active territories expanded.

Mobia Medical (NASDAQ:MOBI) reported second-quarter revenue of $13.5 million, up 102% from $6.7 million a year earlier, as adoption of its Vivistim paired vagus nerve stimulation therapy expanded across new and existing stroke-care programs. The company, which completed its initial public offering